USANA Health Sciences, Inc. (USNA)
Consumer Defensive • Packaged Foods
StockNYSEUnited StatesUS90328M1071
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by USANA Health Sciences, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 20:58. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 16 Feb 2027 16:00 | 0.12 | — | — | Upcoming |
| 03 Nov 2026 16:00 | 0.11 | -0.11 | -200.0% | Miss |
| 04 Aug 2026 16:00 | 0.43 | -0.07 | -116.3% | Miss |
| 05 May 2026 16:00 | 0.44 | 0.61 | +38.6% | Beat |
| 17 Feb 2026 16:00 | 0.41 | 0.60 | +46.3% | Beat |
| 22 Oct 2025 16:00 | -0.15 | -0.15 | 0.0% | In line |
| 22 Jul 2025 16:00 | 0.54 | 0.74 | +37.0% | Beat |
| 22 Apr 2025 16:00 | 0.70 | 0.73 | +4.3% | Beat |
| 25 Feb 2025 16:00 | 0.49 | 0.64 | +30.6% | Beat |
| 22 Oct 2024 16:00 | 0.49 | 0.56 | +15.5% | Beat |
| 23 Jul 2024 16:00 | 0.65 | 0.54 | -16.9% | Miss |
| 30 Apr 2024 16:00 | 0.69 | 0.86 | +24.6% | Beat |
| 06 Feb 2024 16:00 | 0.52 | 0.87 | +68.9% | Beat |
| 24 Oct 2023 16:00 | 0.64 | 0.59 | -7.1% | Miss |
| 25 Jul 2023 16:00 | 0.70 | 0.89 | +28.1% | Beat |
| 25 Apr 2023 16:00 | 0.77 | 0.95 | +23.4% | Beat |
| 07 Feb 2023 16:00 | 0.35 | 0.66 | +88.6% | Beat |
| 25 Oct 2022 16:00 | 0.89 | 0.78 | -12.4% | Miss |
| 26 Jul 2022 16:00 | 1.05 | 1.00 | -4.8% | Miss |
| 26 Apr 2022 16:00 | 1.14 | 1.15 | +0.9% | In line |
| 08 Feb 2022 16:00 | 1.28 | 1.03 | -19.5% | Miss |
| 26 Oct 2021 16:00 | 1.35 | 1.36 | +0.7% | In line |
| 27 Jul 2021 16:00 | 1.78 | 1.87 | +5.1% | Beat |
| 27 Apr 2021 16:00 | 1.57 | 1.45 | -7.6% | Miss |
| 09 Feb 2021 16:00 | 1.39 | 1.87 | +35.0% | Beat |
| 20 Oct 2020 16:00 | 1.29 | 1.44 | +11.6% | Beat |
| 21 Jul 2020 16:00 | 1.19 | 1.32 | +10.9% | Beat |
| 21 Apr 2020 17:00 | 0.57 | 1.23 | +115.8% | Beat |
| 04 Feb 2020 16:00 | 0.98 | 1.41 | +43.9% | Beat |
| 22 Oct 2019 16:00 | 0.87 | 1.09 | +25.3% | Beat |
| 23 Jul 2019 16:00 | 0.93 | 0.91 | -1.6% | Miss |
| 30 Apr 2019 16:00 | 0.99 | 1.01 | +2.0% | Beat |
| 05 Feb 2019 16:00 | 1.29 | 1.32 | +2.7% | Beat |
| 23 Oct 2018 16:00 | 1.10 | 1.24 | +12.7% | Beat |
| 24 Jul 2018 16:00 | 1.11 | 1.36 | +22.5% | Beat |
| 24 Apr 2018 16:00 | 1.05 | 1.19 | +13.9% | Beat |
| 06 Feb 2018 16:00 | 1.00 | 1.11 | +11.0% | Beat |
| 24 Oct 2017 16:00 | 0.91 | 1.02 | +12.7% | Beat |
| 25 Jul 2017 16:00 | 1.06 | 0.98 | -7.6% | Miss |
| 02 May 2017 16:00 | 0.92 | 0.86 | -6.5% | Miss |
| 07 Feb 2017 16:00 | 0.95 | 0.87 | -7.9% | Miss |
| 25 Oct 2016 16:00 | 1.07 | 1.20 | +12.5% | Beat |
| 26 Jul 2016 16:00 | 1.02 | 1.03 | +1.5% | Beat |
| 03 May 2016 16:00 | 0.91 | 0.89 | -2.4% | Miss |
| 09 Feb 2016 16:00 | 1.00 | 0.92 | -8.0% | Miss |
| 03 Nov 2015 16:00 | 0.88 | 0.96 | +9.4% | Beat |
| 04 Aug 2015 16:00 | 0.80 | 0.96 | +20.0% | Beat |
| 05 May 2015 16:00 | 0.65 | 0.75 | +15.7% | Beat |
| 10 Feb 2015 16:00 | 0.96 | 0.83 | -14.2% | Miss |
| 28 Oct 2014 16:00 | 0.68 | 0.74 | +7.6% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 925.3M | +8.3% | 10.8M | 1.2% | 0.58 | -73.5% | 8.5M |
| 2024 | 854.5M | -7.2% | 42M | 4.9% | 2.19 | -33.6% | 50.9M |
| 2023 | 921M | -7.8% | 63.8M | 6.9% | 3.30 | -8.1% | 56.1M |
| 2022 | 998.6M | — | 69.4M | 6.9% | 3.59 | — | 93.5M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 12.89 | 12.94 | 12.53 | 12.70 | -1.17% | 153,151 | |
| 11 Nov 2026 | 13.04 | 13.19 | 12.74 | 12.85 | -1.91% | 188,200 | |
| 10 Nov 2026 | 13.67 | 13.86 | 13.04 | 13.10 | -5.42% | 246,900 | |
| 09 Nov 2026 | 13.70 | 14.34 | 13.69 | 13.85 | +1.61% | 258,000 | |
| 06 Nov 2026 | 13.70 | 13.70 | 13.12 | 13.63 | -1.66% | 292,300 | |
| 05 Nov 2026 | 14.56 | 14.87 | 13.73 | 13.86 | -3.28% | 236,900 | |
| 04 Nov 2026 | 12.69 | 14.50 | 12.68 | 14.33 | -3.63% | 303,900 | |
| 03 Nov 2026 | 14.74 | 15.21 | 14.67 | 14.87 | +1.02% | 290,300 | |
| 02 Nov 2026 | 14.51 | 14.90 | 14.43 | 14.72 | +2.87% | 175,900 | |
| 30 Oct 2026 | 14.27 | 14.47 | 14.15 | 14.31 | -0.21% | 141,000 | |
| 1,254 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- USANA Health Sciences Consensus Price Target Cut 12% to $22.44 (opens in a new tab) Fintel · 09 Nov 2026 00:01
- USANA Health Sciences Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 07 Nov 2026 18:14
- Usana Health Sciences Inc (USNA) (Q3 2026) Earnings Call Highlights: Haya Subscriber Growth and ... (opens in a new tab) GuruFocus.com · 05 Nov 2026 03:11
- USANA (USNA) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 04 Nov 2026 20:48
- USANA Health Sciences, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 04 Nov 2026 13:30
- USANA Health Sciences, Inc. (USNA) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 04 Nov 2026 13:04
- Usana Health Sciences Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 04 Nov 2026 12:29
- USANA Health Sciences, Inc. Reports Q3 2026 Net Loss of $(5.6) million and Updates Fiscal 2026 Outlook (opens in a new tab) Fintel · 04 Nov 2026 03:08
- USANA Health Sciences (NYSE:USNA) Stock Drops 14.6% After Q3 Revenue and Earnings Miss (opens in a new tab) ChartMill · 04 Nov 2026 00:20
- USANA Health Sciences (USNA) Reports Q3 Loss, Lags Revenue Estimates (opens in a new tab) Zacks · 03 Nov 2026 21:50
- USANA (NYSE:USNA) misses Q3 2026 revenue estimates, stock drops 14.9% (opens in a new tab) StockStory · 03 Nov 2026 21:41
- USANA Health: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 03 Nov 2026 21:18
- USANA Health Sciences Reports Third Quarter 2026 Results (opens in a new tab) 03 Nov 2026 21:05
- Usana Health Sciences Lowers FY2026 GAAP EPS Guidance from $(0.61) to $(0.90) vs $(0.61) Est (opens in a new tab) Benzinga · 03 Nov 2026 17:22
- Usana Health Sciences Lowers FY2026 Adj EPS Guidance from $0.76 to $0.55 vs $0.76 Est; Lowers FY2026 Sales Guidance from $910.000M to $900.000M vs $908.995M Est (opens in a new tab) Benzinga · 03 Nov 2026 17:22
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 12.85 USD
- Market cap
- 231.5M
- Exchange
- NYSE
- Country
- United States
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 0.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 6.1 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 20.0 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 12.0 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | 10.18× | Good | 15.04× |
| Price / book | 0.45× | Good | 2.13× |
| Price / sales | 0.26× | Good | 0.95× |
| EV / EBITDA | 1.42× | Good | 10.46× |
| Free cash flow yield | 3.6% | Fair | 4.8% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 77.3% | Good | 33.8% |
| Operating margin | 4.3% | Weak | 7.5% |
| Net margin | -2.3% | Weak | 3.3% |
| Return on equity | -5.1% | Weak | 10.3% |
| Return on assets | 3.4% | Fair | 5.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | -2.5% | Weak | 3% |
| EPS growth / year | -45.5% | Weak | 5.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.04× | Good | 0.77× |
| Net debt / EBITDA | -2.54× | Good | 2.49× |
| Interest cover | 60.41× | Good | 5.02× |
| Current ratio | 2.59× | Good | 1.45× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 34.2% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow USNA and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.